bmn 190

1 stories · following the connections

Business

BioMarin Announces EMA Validation of Brineura™ (Cerliponase Alfa) Marketing Authorization Application for Treatment of CLN2 Disease, a Form of Batten Disease

By Nasdaq OMXSep 15, 2016, 12:38 PM UTC